NCT02303821 2025-06-04Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic LeukemiaAmgenPhase 1 Completed141 enrolled 37 charts
NCT00063713 2008-02-11VELCADE in Subjects With Relapsed or Refractory Mantle Cell LymphomaMillennium Pharmaceuticals, Inc.Phase 2 Completed152 enrolled